4.6 Review

Outcome measurement in functional neurological disorder: a systematic review and recommendations

Journal

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 91, Issue 6, Pages 638-649

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp-2019-322180

Keywords

functional neurological disorder; conversion disorder; movement disorders; clinical neurology; neuropsychiatry

Funding

  1. National Institutes of Health (NIH)
  2. Michael J Fox Foundation
  3. NIHR clinician scientist fellowship
  4. NIHR
  5. NIHR Academic Clinical Fellowship in General Adult Psychiatry
  6. Royal College of Psychiatrists Gosling Fellowship
  7. King's College London
  8. King's Institute of Psychiatry, Psychology and Neuroscience (IoPPN) Clinician Investigator Scholarship
  9. National Institute of Neurological Disorders and Stroke Intramural Programme (NIH, USA)
  10. Ministry of Health of the Czech Republic [AZV CR 16-29651]
  11. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002667] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Objectives We aimed to identify existing outcome measures for functional neurological disorder (FND), to inform the development of recommendations and to guide future research on FND outcomes. Methods A systematic review was conducted to identify existing FND-specific outcome measures and the most common measurement domains and measures in previous treatment studies. Searches of Embase, MEDLINE and PsycINFO were conducted between January 1965 and June 2019. The findings were discussed during two international meetings of the FND-Core Outcome Measures group. Results Five FND-specific measures were identified-three clinician-rated and two patient-rated-but their measurement properties have not been rigorously evaluated. No single measure was identified for use across the range of FND symptoms in adults. Across randomised controlled trials (k=40) and observational treatment studies (k=40), outcome measures most often assessed core FND symptom change. Other domains measured commonly were additional physical and psychological symptoms, life impact (ie, quality of life, disability and general functioning) and health economics/cost-utility (eg, healthcare resource use and quality-adjusted life years). Conclusions There are few well-validated FND-specific outcome measures. Thus, at present, we recommend that existing outcome measures, known to be reliable, valid and responsive in FND or closely related populations, are used to capture key outcome domains. Increased consistency in outcome measurement will facilitate comparison of treatment effects across FND symptom types and treatment modalities. Future work needs to more rigorously validate outcome measures used in this population.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available